Claforan and Hepatitis aggravated - a phase IV clinical study of FDA data

Summary:

Hepatitis aggravated is reported as a side effect among people who take Claforan (cefotaxime sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Flagyl, and have Serratia infection.

The phase IV clinical study analyzes which people have Hepatitis aggravated when taking Claforan. It is created by eHealthMe based on reports of 2,524 people who have side effects when taking Claforan from the FDA, and is updated regularly.

What is Claforan?

Claforan has active ingredients of cefotaxime sodium. eHealthMe is studying from 2,527 Claforan users. Check the latest studies of Claforan.

What is Hepatitis aggravated?

Hepatitis aggravated is found to be associated with 1,150 drugs and 433 conditions by eHealthMe. Check the latest studies of Hepatitis aggravated.

On Aug, 11, 2026

2,524 people reported to have side effects when taking Claforan.
Among them, 39 people (1.55%) have Hepatitis aggravated.

Could Claforan cause Hepatitis aggravated?

Among these 39 people:

How long have people been on Claforan when they have Hepatitis aggravated? *

What is the gender of people who have Hepatitis aggravated when taking Claforan? *

female: 28.95 %
male: 71.05 %

What is the age of people who have Hepatitis aggravated when taking Claforan? *

What are other drugs people take besides Claforan? *

What are other side effects people have besides Hepatitis aggravated? *

Fever: 9 people, 23.08%
Hepatocellular Damage (liver damage): 7 people, 17.95%
Acute Kidney Failure: 6 people, 15.38%
Rash Erythematous (redness of the skin): 6 people, 15.38%
General Physical Health Deterioration (weak health status): 5 people, 12.82%
Liver Function Tests Nos Abnormal: 5 people, 12.82%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 4 people, 10.26%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 4 people, 10.26%
Thrombocytopenia (decrease of platelets in blood): 4 people, 10.26%
Weakness: 3 people, 7.69%

What are the existing conditions these people have? *

Staphylococcal Infection (an infection with staphylococcus bacteria): 3 people, 7.69%
Serratia Infection (bacterial infection): 3 people, 7.69%
Fever: 2 people, 5.13%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 5.13%
Upper Respiratory Tract Infection: 1 person, 2.56%
Staphylococcal Sepsis (blood infection by an infection with staphylococcus bacteria): 1 person, 2.56%
Meningitis Meningococcal (a bacterial infection of the membranes covering the brain and spinal cord (meninges)): 1 person, 2.56%
Lyme Disease (a bacterial infection that is spread to humans by infected ticks): 1 person, 2.56%
Lung Disorder (lung disease): 1 person, 2.56%
Intervertebral Discitis (infection in the intervertebral disc space): 1 person, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Claforan and have Hepatitis aggravated?

- Check whether Hepatitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Claforan:

Claforan (2,527 reports)

Browse all side effects of Claforan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis aggravated:

Hepatitis aggravated (1,150 drugs)

Browse all the conditions that are associated with Hepatitis aggravated:

Hepatitis aggravated (433 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefotaxime sodium (the active ingredients of Claforan) and Claforan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.